Institute of Chemical Biology and Fundamental Medicine, SB RAS, Novosibirsk 630090, Russia.
Novosibirsk State University, Novosibirsk 630090, Russia.
Nucleic Acids Res. 2019 May 7;47(8):3811-3827. doi: 10.1093/nar/gkz120.
Poly(ADP-ribosyl)ation (PARylation) is posttranslational modification of proteins by linear or branched chains of ADP-ribose units, originating from NAD+. The central enzyme for PAR production in cells and the main target of poly(ADP-ribosyl)ation during DNA damage is poly(ADP-ribose) polymerase 1 (PARP1). PARP1 ability to function as a catalytic and acceptor protein simultaneously made a considerable contribution to accumulation of contradictory data. This topic is directly related to other questions, such as the stoichiometry of PARP1 molecules in auto-modification reaction, direction of the chain growth during PAR elongation and functional coupling of PARP1 with PARylation targets. Besides DNA damage necessary for the folding of catalytically active PARP1, other mechanisms appear to be required for the relevant intensity and specificity of PARylation reaction. Indeed, in recent years, PARP research has been enriched by the discovery of novel PARP1 interaction partners modulating its enzymatic activity. Understanding the details of PARP1 catalytic mechanism and its regulation is especially important in light of PARP-targeted therapy and may significantly aid to PARP inhibitors drug design. In this review we summarize old and up-to-date literature to clarify several points concerning PARylation mechanism and discuss different ways for regulation of PAR synthesis by accessory proteins reported thus far.
聚(ADP-核糖)化(PARylation)是蛋白质通过 NAD+ 衍生的线性或支链 ADP-核糖单位的翻译后修饰。细胞中 PAR 产生的核心酶和 DNA 损伤过程中聚(ADP-核糖)化的主要靶标是聚(ADP-核糖)聚合酶 1(PARP1)。PARP1 能够同时作为催化和受体蛋白发挥作用,这为积累相互矛盾的数据做出了相当大的贡献。这个主题直接涉及其他问题,例如自动修饰反应中 PARP1 分子的化学计量、PAR 延伸过程中链生长的方向以及 PARP1 与 PARylation 靶标的功能偶联。除了 DNA 损伤对于折叠催化活性 PARP1 是必需的之外,似乎还需要其他机制来实现 PARylation 反应的相关强度和特异性。事实上,近年来,PARP 研究因发现新型 PARP1 相互作用伙伴而得到丰富,这些伙伴调节其酶活性。了解 PARP1 催化机制及其调控的细节尤为重要,因为这与 PARP 靶向治疗有关,并可能极大地有助于 PARP 抑制剂的药物设计。在这篇综述中,我们总结了旧的和最新的文献,以澄清有关 PARylation 机制的几个要点,并讨论了迄今为止报道的辅助蛋白对 PAR 合成的不同调节方式。